MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,965,000 | +15.0% | 83,752 | +10.7% | 0.03% | +11.1% |
| Q4 2014 | $2,578,000 | -11.0% | 75,677 | +0.8% | 0.03% | -34.1% |
| Q3 2014 | $2,896,000 | +2.2% | 75,079 | +3.1% | 0.04% | +2.5% |
| Q2 2014 | $2,834,000 | +33.7% | 72,826 | +17.5% | 0.04% | +29.0% |
| Q1 2014 | $2,119,000 | +125.2% | 61,969 | +38.2% | 0.03% | +93.8% |
| Q4 2013 | $941,000 | +131.8% | 44,838 | +159.3% | 0.02% | +100.0% |
| Q3 2013 | $406,000 | -11.4% | 17,295 | +1.4% | 0.01% | -11.1% |
| Q2 2013 | $458,000 | – | 17,058 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |